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BACKGROUND: Rapid thrombelastography (rTEG) is a real-time whole-blood viscoelastic coagula-
tion assay. We hypothesized that admission rTEG and clinical data are independent predictors of
trauma-related mortality.
METHODS: Prospective observational data (patient demographics, admission vital signs, laboratory
studies, and injury characteristics) from trauma patients enrolled within 6 hours of injury were
collected. Mann–Whitney U test and analysis of variance test assessed significance (P % .05). Logistic
regression analyses determined the association of the studied variables with 24-hour mortality.
RESULTS: Seven hundred ninety-five trauma patients were enrolled, of which 55 died within
24 hours of admission. Admission variables which independently predicted 24-hour mortality were
as follows: Glasgow Coma Scale %8, hemoglobin ,11 g/dL, international normalized ratio .1.5,
Ly30 .8%, and penetrating injury (P , .05). This 5-variable model’s area under the receiver operator
characteristic curve was .88. The Hosmer–Lemeshow goodness-of-fit test was .90.
CONCLUSIONS: This 5-variable model provides a rapid prediction of 24-hour mortality. The inclu-
sion of rTEG Ly30 demonstrates the association of fibrinolysis with outcome and may support the early
use of antifibrinolytic therapies.
 2014 Elsevier Inc. All rights reserved.The accuracy of mortality predictive models has
paralleled the interpretation of anatomic injury, physio-
logic components, and laboratory tests. In the 1970s, the
American Medical Association’s Committee on Medical
Aspects of Automotive Safety developed a predictive
model utilizing anatomic injuries sustained during motor
vehicle collisions.1,2 The Abbreviated Injury Scale wasnterest.
study.
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13.12.009based on body region and graded injuries on a 1 (minor)
through 6 (lethal) scale. This pioneering model was limited
and under estimated mortality in the elderly, head injured,
and patients with multiple injuries in a single body region
or injuries within multiple body regions. The Injury
Severity Score (ISS) and new ISS (NISS) overcame these
limitations by addressing multiple simultaneous injuries
within single and multiple body regions.3,4 Both the
Abbreviated Injury Scale and ISS were primarily devel-
oped to predict outcomes in blunt trauma.
The evolution of these early prediction models diverged
from solely assessing anatomic injuries to addressing
physiologic characteristics, or a combination of the two.
The introduction of physiologic parameter models such as
D.A. Hampton et al. Mortality predictive model 643the Trauma Score (TS), revised TS (rTS), and Physiologic
Trauma Score (PTS) accounted for patient characteristics
which change secondary to trauma.5–7 The individual’s
response and physiologic reserve became factors inmortality
prediction. Unlike an anatomic injury, physiologic response
is unique to the patient. Inclusion of these measures has
improved the accuracy of mortality prediction models.8
More recently, the Trauma and Injury Severity Score
(TRISS), a weighted scoring system utilizing rTS, ISS, and
age, has been extensively used as a mortality prediction
tool and quality assurance measure.9,10
Because of processing latency, the integration of labo-
ratory results into predictive modeling has been difficult. In
a trauma setting, clinicians often act upon information
which is several hours old. Real-time information more
accurately directs patient care. Expedient laboratory tests
such as rapid thrombelastography (rTEG), a 5-variable
viscoelastic measure of coagulation, is becoming a main-
stream tool. rTEG has been able to provide early coagula-
tion assessment and to direct care of trauma patients.11–13
Given these findings, we proposed that rTEG values and
known physiologic parameters can predict 24-hour trauma
mortality.Methods
Prospective observational data from 3 level-1 trauma
centers (Oregon Health & Science University, San Fran-
cisco General Hospital, and Hermann Memorial Hospital)
were obtained. Institutional research board approval was
granted at each site. Major trauma patients transported
directly to the emergency roommeeting the highest level of
activation at each of the 3 centers with one or more
physiologic or anatomic derangements were eligible
(Table 1). Prisoner status, age ,18 years, history of preho-
spital cardio-pulmonary resuscitation, and burns .20%
body surface area were excluded.Table 1 Physiologic and anatomic inclusion criteria
Physiologic Anatomic
GCS ,10 Penetrating torso trauma
SBP ,90 mmHg Groin/neck injury
RR ,10 or
.29 breaths/min
Amputation proximal to wrist/ankle
HR .120 beats/min Uncontrolled external hemorrhage




Major trauma patients meeting the highest level of trauma
activation and sustaining one or more physiologic or anatomic
derangements were included in the study.
BE 5 base excess; GCS 5 Glasgow Coma Scale; HR 5 heart rate;
RR 5 respiratory rate; SBP 5 systolic blood pressure; TBSA 5 total
body surface area.Patient demographic data – age, sex, systolic blood
pressure (SBP), heart rate (HR), respiratory rate (RR), and
Glasgow Coma Scale (GCS) – were obtained. Injury data
– mechanism (blunt vs penetrating), ISS, and 24-hour
mortality data – were collected. Conventional coagulation
parameters (CCP) – prothrombin (PT), partial thrombo-
plastin (PTT), international normalized ratio (INR),
fibrinogen (FIB), and platelet count (PLT) – and rTEG
data – activated clotting time (ACT), R - time to onset of
clotting, K - rate of clot formation, alpha angle - rate of
fibrin cross-linking, MA - maximum amplitude or clot
strength, and Ly30 - degree of clot lysis 30 minutes after
maximal clot strength was achieved - were also acquired.
All CCP, rTEG, and hemoglobin (Hgb) labs were drawn
upon admission to the emergency department. Collection
protocols and lab parameters were standardized among the
centers. In accordance with protocol, the TEG machines
underwent daily quality control testing with 2 levels of
controls.
All data were analyzed to determine if they were
normally distributed. All nonparametric data were
analyzed using Mann–Whitney U tests and all parametric
data were analyzed using analysis of variance tests. Signif-
icance was set at P% .05. Selected data were dichotomized
based on their known association with mortality and the
manufacturer’s coagulopathy parameters (Table 2).14–16
Variables that were found to be predictive of mortality in
univariate analysis were analyzed using a backward condi-
tional logistic regression to determine their independent as-
sociation with 24-hour mortality. Because of incomplete
data, those variables that were found to be independent pre-
dictors of 24-hour mortality were reanalyzed using a logis-
tic regression. The model’s predictive ability was assessed
using the Hosmer–Lemeshow (HL) goodness-of-fit statistic
and the area under the receiver operator characteristic
(AUROC) curve.17–19Results
There were 795 patients in the study (Table 3). Seven
hundred forty patients survived for 24 hours and 55 patients
did not. Mortality was associated with a lower GCS and
SBP, and a higher ISS. Seventy-four patients did not have
a mechanism of injury recorded. Penetrating injury (n 5
192) was associated with a higher mortality rate (11% vs
6%; P 5 .02) and a lower ISS (14 [interquartile range:
5,15] vs 22 [interquartile range: 14,33]; P , .01) as
compared with blunt injury (n 5 529).
Admission laboratory studies were available on every
trauma patient. Twenty-four hour mortality was associated
with a larger BE and a lower Hgb and PLT (Table 3). PT,
PTT, and INR were prolonged and FIB was decreased in
the mortality group. rTEG ACT, R, and K were longer,
and the alpha angle and MA were lower in the mortality
group. Ly30 was greater in the mortality group, and a larger
percentage of patients who died had an Ly30.8% which is
Table 2 Dichotomous variables for logistic regression
Physiologic CCP rTEG
GCS %8 PT .14 sec ACT .118 sec
SBP %90 mmHg PTT .35 sec Alpha ,64
Hgb ,11 g/dL INR .1.5 MA ,52 mm
BE ,26 mEq/L FIB ,200 mg/dL Ly30 .8 mm
PLT ,150 ! 103/mm3
ACT 5 activated clotting time; BE 5 base excess; CCP 5 conventional coagulation parameters; FIB 5 fibrinogen; GCS 5 Glasgow Coma Scale; Hgb 5
hemoglobin; INR5 international normalized ratio; Ly305 degree of clot lysis 30 minutes after maximal clot strength; MA5 maximum amplitude; PLT5
platelet count; PT 5 prothrombin; PTT 5 partial thromboplastin; rTEG 5 rapid thrombelastography; SBP 5 systolic blood pressure.
644 The American Journal of Surgery, Vol 207, No 5, May 2014the limit of the normal range as defined by the manufac-
turer (28% [n 5 12] vs 3% [n 5 21]; P , .01).
When the demographic, hematologic, and CCP data
associated with mortality were analyzed in a backward
conditional logistic regression, GCS, SBP, INR, and pene-
trating injury were found to be independent predictors of
mortality (Table 4). Using these 4 variables, the AUROC was
.86 and the HL goodness-of-fit was .37 (Fig. 1). When the
rTEG parameters were included in an identical analysis,
GCS, Hgb, INR, Ly30, and penetrating mechanism of injury
were independent predictors of mortality. Using these 5 vari-
ables, theAUROCwas .88 and theHLgoodness-of-fitwas .90.
Comments
We developed a 5-variable 24-hour mortality prediction
model based on biochemical and physiologic data available
within 30 minutes of admission to the resuscitation bay.Table 3 Demographic and admission laboratory data for 795 trauma
Survived (n 5 740)
Age (years old) 38 (26, 52)
GCS 15 (3, 15)
SBP (mmHg) 130 (108, 148)
HR (beats per minute) 96 (81, 115)
RR (respirations per minute) 20 (16, 24)
ISS 19 (10, 29)
Base excess (mEq/L) 22.7 (26.0, .5)
Hgb (mg/dL) 13.6 (12.2, 14.8)
PLT (!106/L) 235 (190, 284)
PT (sec) 13.9 (13.2, 14.9)
PTT (sec) 27.2 (24.6, 30.4)
INR 1.1 (1.0, 1.2)
Fibrinogen (mg/dL) 264 (215, 317)
ACT (sec) 113 (105, 128)
R (sec) 42 (36, 48)
Alpha (degrees) 74 (70, 77.0)
K (sec) 84 (66, 108)
MA (mm) 63 (59, 67)
Ly30 (%) 1.1 (.2, 2.4)
P % .05.
GCS 5 Glasgow Coma Scale; Hgb 5 hemoglobin; HR 5 heart rate; INR 5 in
count; PT 5 prothrombin; PTT 5 partial thromboplastin; ACT 5 activated clott
Ly30 5 degree of clot lysis 30 minutes after maximal clot strength; MA 5 ma
SBP 5 systolic blood pressure.The inclusion of Ly30 demonstrates the association of
fibrinolysis with mortality suggesting a potential benefit of
administering tranexamic acid (TXA) during resuscitation.
The 4-variable model, which did not include rTEG data,
produced a similar AUROC profile, but its ability to predict
the observed results was poorly calibrated and significantly
inferior based on the HL goodness-of-fit. This discrepancy
may have been a product of meeting the fibrinolysis
threshold, which was seen significantly more frequently
in the mortality group.
The ISS was validated in 1974 as a predictor of mortality
after motor vehicle trauma.3 Its limitation, not accounting
for multiple injuries to single body region, was overcome
by the NISS.4 In a 4-year study at 2 level-1 trauma centers,
the NISS possessed a larger AUROC and a better goodness-
of-fit as compared to ISS calculations on the same popula-
tion. Conversion to a NISS system should have been
seamless; however, it has not been widely employed.patients
Died (n 5 55) P value
39 (25, 61) .39
3 (3, 3) ,.01
109 (78, 137) ,.01
101 (76, 129) .4
18 (16, 22) .23
28 (25, 38) ,.01
26.6 (212.2, 3.0) ,.01
11.0 (9.7, 13.2) ,.01
178 (223, 143) ,.01
17.2 (15.7, 20.4) ,.01
38.3 (31.9, 51.9) ,.01
1.4 (1.3, 1.7) ,.01
199 (128, 297) ,.01
121 (113, 144) ,.01
48 (42, 60) ,.01
69 (55, 73) ,.01
114 (75, 192) ,.01
58 (49, 63) ,.01
2.1 (.2, 15) ,.01
ternational normalized ratio; ISS 5 Injury Severity Score; PLT 5 platelet
ing time; Alpha 5 rate of fibrin cross-linking; K 5 rate of clot formation;
ximum amplitude; R 5 time to onset of clotting; RR 5 respiratory rate;
Table 4 Backward conditional regression models using solely conventional coagulation parameters and with the inclusion of rapid
thrombelastography parameters
OR (95% CI) P value HL
Model with CCP
GCS %9 11.1 (4.0–30.8) ,.01 .37
SBP ,100 (mmHg) 2.5 (1.0–5.9) .05
INR .1.5 9.6 (4.1–22.6) ,.01
Penetrating 5.4 (2.4–12.0) ,.01
Model with rTEG
GCS %9 8.0 (2.8–22.7) ,.01 .90
INR .1.5 7.4 (3.0–18.3) ,.01
Hgb ,11 (mg/dL) 4.0 (1.7–9.1) ,.01
Ly30 .8 (%) 3.7 (1.2–12.1) .03
Penetrating 5.0 (2.2–11.4) ,.01
P % .05.
CCP 5 conventional coagulation parameters; CI 5 confidence interval; GCS 5 Glasgow Coma Scale; Hgb 5 hemoglobin; HL 5 Hosmer–Lemeshow;
INR 5 international normalized ratio; Ly30 5 degree of clot lysis 30 minutes after maximal clot strength; OR 5 odds ratio.
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trauma data; the inclusion of physiologic parameters
increased their predictive ability. Derived from the Triage
Index, a prehospital assessment tool, Champion’s TS uti-
lized the following physiologic parameters: SBP, RR,
capillary refill, respiratory expansion, and GCS.5,20 These
readily measurable parameters made the TS a desirable
tool; however, capillary refill and respiratory expansion
were difficult to assess in the field. The exclusion of these
variables lead to the rTS, a 3-variable model which was
easier to apply, and gave a larger weighting to the GCS
score.6 This resulted in a more accurate characterization of
head injured patients. The rTS was the basis for the TRISS,
a comprehensive model which also incorporates ISS and
age.9 This methodology offered a consistent mortality pre-
diction model and was used in the Major Trauma Outcome
Study as the standard for patient and treatment evaluation
measures.10 The TRISS, however, was restricted by the la-
tency to calculate ISS upon admission. The ISS was notFigure 1 Receiver operator curves for the 4-variable and
5-variable models.known until an operative intervention or autopsy was
performed.
The expediency of admission laboratory work resulted
in the development of the PTS, a model which combined
the systemic inflammatory response syndrome score, GCS,
and age.7 The presence of systemic inflammatory response
syndrome has been found to be an independent predictor of
mortality and intensive care unit admission.21,22 In a logis-
tic regression analysis using data from over 9,000 trauma
patients, no difference was seen between PTS and TRISS.7
Its feasibility, ease of calculation, and equivalence to
TRISS made PTS an attractive mortality model.
Our institution recently published a simple model for
massive transfusion (MT).23 This study was a retrospective
cohort analysis of 558 combat casualties received at 2 com-
bat support hospitals in Iraq. Two hundred forty-seven pa-
tients received an MT, and 311 did not. Patient variables
associated with an MT underwent a stepwise logistic
regression. Those found to be independent predictors of
an MT, the Schreiber Score (SS), were the following: he-
moglobin %11 g/dL, INR .1.5, and penetrating mecha-
nism of injury. This simple scoring system is a validated
tool for early goal-directed resuscitation in trauma
patients.24
The SS, combined with Ly30 and GCS, is our 24-hour
mortality prediction model. This extended Schreiber Score
(eSS) segues from an MT to a mortality model. Similar to
TRISS and rTS, the inclusion of GCS may allow for an
increased accountability for head injured patients. The
inclusion of Ly30, a measure of fibrinolysis, underscores
the utility of TEG, and the potential benefit of TXA, a
lysine analogue which inhibits fibrinolysis by competi-
tively binding to plasminogen and plasmin, thus prevent-
ing degradation of fibrin. TXA has been associated with
decreased mortality in civilian and military settings and
has become a front line agent for battle field injuries.25,26
The Clinical Randomization of an Antifibrinolytic in Sig-
nificant Hemorrhage-2 trial was a prospective study
646 The American Journal of Surgery, Vol 207, No 5, May 2014involving over 20,000 civilian trauma patients admitted to
274 hospitals in 40 countries.25 Patients who received
TXA within the 1st hour after trauma experienced
decreased mortality due to hemorrhage (TXA [5.3%] vs
placebo [7.7%]; P , .0001). This benefit was also noted
for those patients who received TXA within 1 to 3 hours
of their injuries (TXA [4.8%] vs placebo [6.1%]; P 5
.03). This landmark investigation was limited by the use
of clinical findings as inclusion criteria, study patients
who may have not been actively bleeding, and a large
study population may have led to a type II error. The Mil-
itary Application of Tranexamic Acid in Trauma Emer-
gency Resuscitation study was a retrospective
observational study involving 896 combat traumas who
received at least 1 unit of packed red blood cells.26 Those
receiving TXA (17.4%) had a lower mortality rate than
those who did not (23.9%; P 5 .03). Even though Military
Application of Tranexamic Acid in Trauma Emergency
Resuscitation study was limited by missing 30-day
outcome data from host nation patients and the inability
to discern the cause or timing of death, it was able to
demonstrate improvement of coagulopathy and survival
in those receiving TXA. Ly30, TXA, and mortality are
intimately connected. The SS evolving into the eSS repre-
sents a seamless transition in patient outcome prediction
and a continuum of care.
There were limitations to our study. This was a pro-
spective study performed at 3 geographically separated
institutions. The patient populations, injuries seen, and
practice patterns may have varied. A patient’s medical
history was not known at the time of enrollment, therefore
medications or pre-existing conditions which could affect
coagulation were not known. There was no accountability
or standardization for prehospital or hospital interventions.
Centralized processing of data was not performed, there-
fore some patient data were incomplete. Finally, the study
variables’ covariance between each other may have intro-
duced a level of bias into the regression analysis.
We have developed a novel 5-variable 24-hour mortality
prediction model. It incorporates our previous MT model,
SS, with GCS, a variable which increased the previous
models’ predictive ability by accounting for head injuries
and severe shock, and Ly30, a measure of thrombolysis.
Our model demonstrates a high level of functionality by
exploiting variables which are readily available within the
trauma bay and has the potential to be used as a real-time
predictive score in the treatment of trauma patients.
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Discussion
Matthew J. Martin, M.D.: One of the most difficult
tasks in trauma care, and in all of medicine, is being able
to separate concepts that meaningfully change the way
we do business from transient fads or trends that eventually
fizzle out and die. This paper touches on several current
trends that are being widely implemented and discussed,
but are still awaiting that ultimate test of time: these include
damage control resuscitation, tranexamic acid, and the use
of thromboelastography (TEG) in the initial trauma evalu-
ation. For the purposes of full disclosure, I will admit
that I am the senior author on another paper being pre-
sented at this meeting that focuses on the utility of rota-
tional thromboelastometry, or ROTEM, which is
essentially a TEG with a European accent.
I have several comments and questions for the authors,
and as always I look forward to Dr. Schreiber’s responses
and insights:
1. The first comment is really a philosophical question -
although we talk about various scoring systems for
predicting everything from the need for blood transfusion
to whether the patient will ultimately live or die, does
anyone actually use any of these scoring systems in the
emergent clinical setting? I take comfort in the fact thatthese incredibly complex and multi-variate decision pro-
cesses still require a human brain capable of considering
both hard data and the more nebulous ‘‘gestalt’’ from an
injured patient. Are you using this scoring system at OHSU,
and if so, how?
2. A major criticism of scoring systems such as ISS and
TRISS is that they are not useful or even available at the
initial evaluation, when hard decisions need to be made.
Physiologic variables like heart rate and blood pressure are
immediately available, and with modern point of care
devices most lab values can be obtained within minutes of
patient arrival. How useful is a test like LY30 that requires
30 minutes in addition to the time required to obtain the
sample, start the test, and report the result?
3. As your data shows, there is really no difference in the
area under the ROC curves for the 4-variable model versus
the model with additional TEG data. What is the benefit of
adding the LY30, or other TEG measures, in terms of
mortality prediction? How does adding this variable
significantly improve the goodness of fit of the model,
but not the predictive ability?
4. Finally, it must be stated that the jump from the study
results to the conclusion that early TXA use is indicated is
entirely speculative. The CRASH-2 and MATTERS studies
did not use any measure of fibrinolysis as an indication for
TXA administration. Is an elevated LY30 an absolute
indication for TXA, and more importantly, is a normal
LY30 enough reason to withhold giving TXA?
Only time will tell whether the use of TEG or ROTEM in
trauma resuscitation becomes a standard of care or a passing
fad. The most important factor in making that determination
will be the continued collection and reporting of robust data
and outcomes as demonstrated by Dr. Schreiber and
colleagues at Oregon Health & Science University.
